ANDA 74381, held by Baxter Hlthcare. Dobutamine Hydrochloride.
As of Nov 16, 2026, ANDA 74381 (Dobutamine Hydrochloride), held by Baxter Hlthcare, was first approved by FDA on Sep 26, 1996, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 26, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Dobutamine HydrochlorideEQ 12.5MG BASE/ML ยท injectable;injection | Dobutamine Hydrochloride | Discontinued |
| Nov 19, 2001 | Supplement 4Labeling | Approved | None posted |
| Oct 16, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Apr 28, 2000 | Supplement 2Manufacturing | Approved | None posted |
| May 9, 1997 | Supplement 1Manufacturing | Approved | None posted |
| Sep 26, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters